Detalhe da pesquisa
1.
Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
J Urol
; 203(2): 338-343, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31437119
2.
How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.
BJU Int
; 122(5): 823-830, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29772103
3.
Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology.
World J Urol
; 36(9): 1489-1494, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29610962
4.
The oncologic role of local treatment in primary metastatic prostate cancer.
World J Urol
; 33(6): 755-61, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24997127
5.
AR-V7 predicting treatment response in metastasized prostate cancer: has it peaked?
World J Urol
; 36(1): 149-151, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29086020
6.
Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer.
Eur Urol Focus
; 8(6): 1599-1606, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35317972
7.
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
Eur Urol Oncol
; 4(5): 745-754, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33243663
8.
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer.
Cancer Med
; 10(18): 6354-6364, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374489
9.
Hereditary prostate cancer - Primetime for genetic testing?
Cancer Treat Rev
; 81: 101927, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31783313
10.
Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment.
Eur Urol Focus
; 5(2): 171-178, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801241
11.
Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey.
Urol Oncol
; 36(12): 529.e11-529.e22, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30301698
12.
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients.
Urol Oncol
; 33(2): 71.e1-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25131660
13.
Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling.
Arch Esp Urol
; 68(3): 296-306, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25948801
14.
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series.
Urol Oncol
; 33(4): 164.e1-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25620154
15.
Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling / Biopsia de próstata sistemática guiada por ecografía por saturación y utilizando plantilla: indicaciones y ventajas de la ampliación del número de muestras
Arch. esp. urol. (Ed. impr.)
; 68(3): 296-306, abr. 2015. tab
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-136563